Capstone Therapeutics's total assets for Q2 2025 were $51.88M, a decrease of -0.62% from the previous quarter. CAPS total liabilities were $8.64M for the fiscal quarter, a -65.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.